FDA reports new deaths with diabetes drug Byetta

Aug 18, 2008 By MATTHEW PERRONE , AP Business Writer

(AP) -- Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths continue to be reported despite earlier government warnings.



Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Explore further: NIH begins early human clinical trial of VSV Ebola vaccine

add to favorites email to friend print save as pdf

Related Stories

Wireless sensor transmits tumor pressure

Sep 20, 2014

The interstitial pressure inside a tumor is often remarkably high compared to normal tissues and is thought to impede the delivery of chemotherapeutic agents as well as decrease the effectiveness of radiation ...

Short nanotubes target pancreatic cancer

Jun 05, 2014

(Phys.org) —Short, customized carbon nanotubes have the potential to deliver drugs to pancreatic cancer cells and destroy them from within, according to researchers at Rice University and the University ...

Functional nerve cells from skin cells

May 21, 2014

A new method of generating mature nerve cells from skin cells could greatly enhance understanding of neurodegenerative diseases, and could accelerate the development of new drugs and stem cell-based regenerative ...

Recommended for you

Added benefit of vedolizumab is not proven

6 hours ago

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

Sepp
5 / 5 (1) Aug 18, 2008
Pretty bad when a drug for a condition that can be controlled by dietary means causes people to die of pancreatitis. What does the FDA? Require a warning.

In contrast, when a natural nutrient product causes similar trouble, the answer is usually to ban that product outright.

Double standard?